Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > ICO will return to 0.04 ¢ soon. Way too much pumping Bashers

<< Previous

Bullboard Posts

Next >>

Comment by mmayeron Dec 03, 2020 3:12pm

74 Views

Post# 32030288

RE:ICO will return to 0.04 ¢ soon. Way too much pumping Bashers

Pumping bashers? LOL, now there's a concept!

Pierretraderman wrote: No news to come according to some analysts and brokers only end of year sale for tax loss. Don't bite the Corrupted Bashers' hook.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features